8,517 articles
John A. Bevan
John A. Bevan (1930–2007) was a British-born vascular pharmacologist known for work on vascular tone, adrenergic mechanisms, and the cerebral circulation, and as a pioneer of vascular pharmacology.
John A. Bittl
John A. Bittl is an American interventional cardiologist trained at Johns Hopkins and Harvard, known for the 1995 Hirulog Angioplasty Study comparing bivalirudin with heparin.
John A. Branda
John A. Branda is an American clinical pathologist and clinical microbiologist at Massachusetts General Hospital and Harvard Medical School, known for improving serologic testing for early Lyme disease.
John A. Clements
John A. Clements (1923–2024) was an American pulmonary physiologist at UCSF who discovered pulmonary surfactant, designed Exosurf, and won the 1994 Lasker Award; his work raised premature infant survival.
John A. Eisman
John A. Eisman is an Australian endocrinologist and bone researcher who led the Garvan Institute's osteoporosis division for nearly three decades and founded the Dubbo Osteoporosis Epidemiology Study in 1989.
John A. Flynn
John A. Flynn is an American rheumatologist and medical educator at Johns Hopkins, where he directed the spondyloarthritis program and a Johns Hopkins professorship was dedicated to him in 2015.
John A. Hansen
John A. Hansen was an American transplant immunologist who spent four decades at Fred Hutchinson Cancer Research Center, performed an early unrelated-donor marrow transplant in 1979, and helped launch the National Marrow Donor Program.
John A. Jernigan
John A. Jernigan, also published as John Jernigan, is an American infectious diseases physician and epidemiologist directing CDC research on healthcare-associated infections and antibiotic resistance.
John A. Kastor
John A. Kastor is an American cardiologist who helped establish clinical cardiac electrophysiology at the University of Pennsylvania and chaired medicine at the University of Maryland from 1984.
John A. Kellum
John A. Kellum, also known as John Kellum, is an American critical care nephrologist at the University of Pittsburgh known for his work on acute kidney injury and sepsis.
John A. Luetscher
John A. Luetscher (1913–2005) was an American endocrinologist at Stanford University who spent over 40 years there, isolated aldosterone, and identified plasma prorenin as a marker of diabetic microvascular disease.
John A. Mannick
John A. Mannick (1928–2019) was an American vascular surgeon and immunologist, chief of surgery at Brigham and Women's Hospital and Moseley Professor at Harvard from 1976 to 1994.
John A. Oates Jr
John A. Oates Jr (John Alexander Oates, 1932–2019) was an American clinical pharmacologist at Vanderbilt University, a founder of clinical pharmacology known for first-pass drug metabolism and eicosanoid research.
John A. Spertus
John A. Spertus is an American cardiologist and outcomes researcher at the University of Missouri–Kansas City, known for developing the Seattle Angina Questionnaire and Kansas City Cardiomyopathy Questionnaire.
John Addison Fordyce
John Addison Fordyce (1858–1925) was an American dermatologist and syphilologist, professor at Bellevue and Columbia, who gave his name to Fordyce spots, the Fordyce lesion, and Fox–Fordyce disease.
John Auer
John Auer (1875–1948) was an American pharmacologist and physiologist who first described Auer rods in leukemia cells in 1906 and, with Samuel Meltzer, developed intratracheal insufflation anesthesia.
John B. Buse
John B. Buse is an American endocrinologist at the UNC School of Medicine who chaired the LEADER trial, which showed liraglutide reduced cardiovascular events in type 2 diabetes.
John B. Dixon
John B. Dixon is an Australian physician-researcher in obesity and bariatric medicine who headed clinical obesity research at the Baker Heart and Diabetes Institute in Melbourne from 2008 to 2020.
John B. Glen
John B. (Iain) Glen is a British veterinarian and pharmacologist who discovered and developed propofol, the most widely used anesthetic, earning the 2018 Lasker~DeBakey Clinical Medical Research Award.
John B. Hibbs
John B. Hibbs, Jr. is an American physician-scientist at the University of Utah known for discovering in 1987 that cytokine-activated macrophages synthesize nitric oxide from L-arginine.
John B. Wong
John B. Wong is an American physician-scientist at Tufts Medical Center in Boston, known for cost-effectiveness modeling of hepatitis B and service on the US Preventive Services Task Force.
John B.A.G. Haanen
John B.A.G. Haanen, also known as John B. Haanen, is a Dutch medical oncologist who leads immunotherapy at the Netherlands Cancer Institute and won the 2024 ESMO Lifetime Achievement Award.
John Benjamin Murphy
John Benjamin Murphy (1857–1916) was an American surgeon in Chicago known for the Murphy button and Murphy's sign, and a founder of the American College of Surgeons.
John Bridgewater
John Bridgewater (John A. Bridgewater) is a British medical oncologist and Clinical Professor at the UCL Cancer Institute, known for the ABC-02 and BILCAP trials defining biliary tract cancer treatment.
John Britton (respiratory physician)
John Richard Britton, born 1955, is a British respiratory physician and epidemiologist at the University of Nottingham who founded the UK Centre for Tobacco and Alcohol Studies.
John Brognard
John Brognard is an American cancer pharmacologist who studies kinase signaling networks in lung, head and neck, and breast cancers, winning a Presidential Early Career Award in 2017.
John Burn (clinical geneticist)
Sir John Burn, born 1952, is a British clinical geneticist at Newcastle University who led trials showing daily aspirin reduces cancer risk in Lynch syndrome.
John C. Ayres
John C. Ayres, M.D., was an American epidemiologist with the Massachusetts Department of Public Health who published on tularemia, encephalitis, and rickettsialpox from 1948 to 1951.
John C. Burnett
John C. Burnett is an American cardiologist and physician-scientist at Mayo Clinic in Rochester, Minnesota, director of its Cardiorenal Research Laboratory, known for establishing natriuretic peptides as heart-failure biomarkers.
John C. Byrd
John C. Byrd is an American physician-scientist in hematologic malignancies who directs UPMC Hillman Cancer Center and led development of the leukemia drugs ibrutinib and acalabrutinib.